| Name: A Phase II Trial of Bryostatin 1 in the Treatment of Metastatic Colorectal Cancer -- Zonder et al. 7 (1): 38 --
Description: The primary end point was tumor response to patients with colorectal cancer have metastatic disease at presentation. Additionally study had a 0.79 power to distinguish regions of
Category: Cancer Colorectal Point Power Presentation
Url: http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=11205915
Date: Oct 7, 2005
Current Rating: 0.00
Clicks/Hits Received: 5 |
|